Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,31 USD | +18,79% | +35,11% | +103,45% |
07/05 | SUMMIT THERAPEUTICS INC. : Citigroup geeft koopadvies | ZM |
01/05 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
Vakgebied
Aantal werknemers: 105
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11-11-20 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01-12-19 |
Director of Finance/CFO | 46 | 01-12-19 | |
Howard West
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-23 |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 16-10-23 |
Will Black
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dave Gancarz
PRN | Corporate Officer/Principal | - | - |
Campbell Hair
HRO | Human Resources Officer | - | 01-10-20 |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03-11-21 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 01-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01-12-19 |
Robert Booth
BRD | Director/Board Member | 70 | 28-09-22 |
Director of Finance/CFO | 46 | 01-12-19 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11-11-20 |
Kenneth Clark
BRD | Director/Board Member | 65 | 07-10-21 |
Director/Board Member | 63 | 15-11-22 | |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03-11-21 |
Michelle Xia
BRD | Director/Board Member | 58 | 16-01-23 |
Ujwala Mahatme
BRD | Director/Board Member | 59 | 13-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 701 979 596 | 83 412 497 ( 11,88 %) | 0 | 11,88 % |
Bedrijfsgegevens
Sector
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+103,45% | 3,73 mld. | |
+10,44% | 107 mld. | |
+0,82% | 106 mld. | |
+8,33% | 23,47 mld. | |
-13,89% | 21,9 mld. | |
-6,03% | 18,77 mld. | |
-37,26% | 17,85 mld. | |
-10,98% | 16,78 mld. | |
+8,67% | 14,41 mld. | |
+41,08% | 12,86 mld. |
- Beurs
- Aandelen
- Koers SMMT
- Onderneming Summit Therapeutics Inc.